Financials

  • Market Capitalization 949.4 M
  • Employee 489
  • Founded 2007
  • CEO Mike Raab
  • Website www.ardelyx.com
  • Headquarter Delaware, United States
  • FIGI BBG001WH4DQ3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-22.42
Rapporto prezzo/fatturato
3.45

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2466
GERN
Geron Corporation - Common Stock
1.51 USD-1.31%-1.31%+4.86%+4.86%970.13 M USD
2488
ANNX
Annexon, Inc. - common stock
5.01 USD-4.57%-0.40%+0.80%+136.32%949.79 M USD
2492
DSGN
Design Therapeutics, Inc. - Common Stock
15.17 USD-0.52%-0.72%+27.05%+168.50%949.36 M USD
2508
OLMA
Olema Pharmaceuticals, Inc. - Common Stock
10.36 USD-3.99%-4.25%-9.91%+26.50%906.48 M USD

Notizie